# üìÅ Clinical Analysis Outputs - Navigation Guide

## üìÇ Directory Structure

```
clinical_analysis_outputs/
‚îÇ
‚îú‚îÄ‚îÄ RECLASSIFIED_ANALYSIS/          ‚≠ê START HERE - FINAL CORRECT ANALYSES
‚îÇ   ‚îú‚îÄ‚îÄ 00_START_HERE_RECLASSIFIED.md
‚îÇ   ‚îú‚îÄ‚îÄ README.md
‚îÇ   ‚îú‚îÄ‚îÄ RECLASSIFIED_ANALYSIS_SUMMARY.md
‚îÇ   ‚îú‚îÄ‚îÄ apoe_grade_distribution_RECLASSIFIED.png  ‚≠ê USE FOR DR. GUO MEETING
‚îÇ   ‚îú‚îÄ‚îÄ apoe_grade_distribution_RECLASSIFIED_report.txt
‚îÇ   ‚îú‚îÄ‚îÄ apoe_grade_RECLASSIFIED_tables.xlsx
‚îÇ   ‚îú‚îÄ‚îÄ 25_samples_RECLASSIFIED.csv
‚îÇ   ‚îî‚îÄ‚îÄ 25_samples_RECLASSIFIED_metadata.xlsx
‚îÇ
‚îú‚îÄ‚îÄ Other files (previous analyses, survival plots, etc.)
‚îî‚îÄ‚îÄ 00_NAVIGATION_GUIDE.md (this file)
```

---

## ‚≠ê FOR DR. GUO MEETING

### **Go to:**
```
RECLASSIFIED_ANALYSIS/
```

### **Open:**
1. **`00_START_HERE_RECLASSIFIED.md`** - Meeting preparation guide
2. **`apoe_grade_distribution_RECLASSIFIED.png`** - Main presentation figure

---

## üìä What's in RECLASSIFIED_ANALYSIS?

### **‚úÖ FINAL CORRECT ANALYSES** where:
- All IDH-wildtype patients ‚Üí WHO Grade IV (GBM)
- 25 patients total
- 23 patients (92%) are WHO Grade IV
  - 20 IDH-wildtype (true GBM)
  - 3 IDH-mutant (aggressive astrocytoma)
- 2 patients (8%) are WHO Grade III (IDH-mutant)

### **Key Files:**
1. **Presentation Figure:** `apoe_grade_distribution_RECLASSIFIED.png`
2. **Patient Data:** `25_samples_RECLASSIFIED.csv`
3. **Detailed Report:** `apoe_grade_distribution_RECLASSIFIED_report.txt`
4. **Data Tables:** `apoe_grade_RECLASSIFIED_tables.xlsx`
5. **Complete Summary:** `RECLASSIFIED_ANALYSIS_SUMMARY.md`
6. **Meeting Guide:** `00_START_HERE_RECLASSIFIED.md`
7. **README:** `README.md`

---

## üìã Other Files in This Directory

### **Previous Analyses:**
- `apoe_grade_distribution_REAL_DATA.png` - Analysis before reclassification (outdated)
- `apoe_grade_REAL_DATA_tables.xlsx` - Tables before reclassification (outdated)

### **Survival Plots (from earlier clinical analysis):**
- `survival_by_apoe_genotype.png` - KM plot by APOE genotype
- `survival_by_Grade.png` - KM plot by WHO grade
- `SURVIVAL_PLOT_UPDATE.md` - Notes on survival plot updates

### **Clinical Overview:**
- `clinical_overview_panel.png` - Multi-panel clinical summary
- `clinical_analysis_results.xlsx` - Clinical analysis results
- `COMPREHENSIVE_CLINICAL_SUMMARY.md` - Detailed clinical summary

### **Documentation:**
- `25_samples_metadata.xlsx` - Original metadata (before reclassification)
- `PANEL_CUSTOMIZATION_NOTES.md` - Notes on panel customization
- `TREATED_COHORT_NOTES.md` - Treatment analysis notes
- `clinical_analysis_manifest.json` - Analysis manifest

---

## üéØ Quick Action Guide

### **For Meeting Presentation:**
1. Go to `RECLASSIFIED_ANALYSIS/`
2. Open `apoe_grade_distribution_RECLASSIFIED.png`
3. Read `00_START_HERE_RECLASSIFIED.md` for talking points

### **For Data Analysis:**
1. Use `RECLASSIFIED_ANALYSIS/25_samples_RECLASSIFIED.csv`
2. Open in R/Python/Excel for further analysis

### **For Detailed Statistics:**
1. Read `RECLASSIFIED_ANALYSIS/apoe_grade_distribution_RECLASSIFIED_report.txt`
2. Open `RECLASSIFIED_ANALYSIS/apoe_grade_RECLASSIFIED_tables.xlsx`

### **For Complete Understanding:**
1. Start with `RECLASSIFIED_ANALYSIS/README.md`
2. Then read `RECLASSIFIED_ANALYSIS/RECLASSIFIED_ANALYSIS_SUMMARY.md`

---

## ‚ö†Ô∏è Important Notes

### **‚úÖ USE THESE (Reclassified):**
- All files in `RECLASSIFIED_ANALYSIS/` subdirectory
- All IDH-wildtype ‚Üí WHO Grade IV
- Biologically accurate
- Ready for presentation/publication

### **‚ùå DON'T USE THESE (Old versions):**
- `apoe_grade_distribution_REAL_DATA.*` files
- These don't have proper IDH-based reclassification
- Kept for reference only

---

## üìû Questions?

- **What is reclassification?** All IDH-wildtype patients are classified as WHO Grade IV (GBM) because they behave aggressively regardless of histological appearance.

- **Why reclassify?** IDH status is the most important prognostic factor in gliomas. IDH-wildtype tumors have poor prognosis similar to GBM, even if they look like lower-grade tumors under the microscope.

- **Which files should I use?** Everything in `RECLASSIFIED_ANALYSIS/` subdirectory.

- **What about the other files?** Previous analyses or different aspects of clinical data. Use `RECLASSIFIED_ANALYSIS/` for APOE grade distribution analysis.

---

**üìç Location:** `D:\APOE\clinical_analysis_outputs\`  
**‚≠ê Start Here:** `RECLASSIFIED_ANALYSIS/00_START_HERE_RECLASSIFIED.md`  
**üìÖ Date:** October 29, 2025

